Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
SciScore for 10.1101/2020.03.23.20041533: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: After the Delphi survey had been completed, a consensus meeting was conducted to determine the final COS. 2.5 Ethics and consent: The entire project is part of a clinical trial of COVID-19, which was approved by the Ethics Committee of Dongzhimen Hospital (DZMEC-KY-2020-09).
Consent: Because of the special circumstances of the COVID-19 pandemic, participants who completed the questionnaire were assumed to have provided consent for their data to be used.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources 2.1 Registry: This COS has been … SciScore for 10.1101/2020.03.23.20041533: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: After the Delphi survey had been completed, a consensus meeting was conducted to determine the final COS. 2.5 Ethics and consent: The entire project is part of a clinical trial of COVID-19, which was approved by the Ethics Committee of Dongzhimen Hospital (DZMEC-KY-2020-09).
Consent: Because of the special circumstances of the COVID-19 pandemic, participants who completed the questionnaire were assumed to have provided consent for their data to be used.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources 2.1 Registry: This COS has been registered on the Core Outcome Measures in Effectiveness Trials (COMET) database [7]. COMETsuggested: (CoMet, RRID:SCR_011925)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Our study had four main limitations. First, due to the highly infectious nature of SARS-CoV-2, patients and the public did not participate in the design or development of the preliminary list of outcomes. Second, the preliminary list of outcomes was developed from protocols of clinical trials when there were knowledge gaps in the prevalence, therapy, prognosis, clinical characteristics of COVID-19. Hence, the COS must be updated in the future. Third, the number of patients was small and all of them were from Hubei Province, so their perspectives may not reflect those of other regions in China or overseas. Fourth, almost all stakeholders were from China. Though one participant in round 1 of the Delphi survey was from Canada, his/her opinion reflected a Chinese perspective because the questionnaire was written in Chinese.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-
-